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Abstract
Classical osteogenesis imperfecta (OI) is a bone disease caused by type I collagen mutations and characterized by bone
fragility, frequent fractures in absence of trauma and growth deficiency. No definitive cure is available for OI and to develop
novel drug therapies, taking advantage of a repositioning strategy, the small teleost zebrafish (Danio rerio) is a particularly
appealing model. Its small size, high proliferative rate, embryo transparency and small amount of drug required make
zebrafish the model of choice for drug screening studies, when a valid disease model is available. We performed a deep
characterization of the zebrafish mutant Chihuahua, that carries a G574D (p.G736D) substitution in the a1 chain of type I
collagen. We successfully validated it as a model for classical OI. Growth of mutants was delayed compared with WT. X-ray,
mCT, alizarin red/alcian blue and calcein staining revealed severe skeletal deformity, presence of fractures and delayed
mineralization. Type I collagen extracted from different tissues showed abnormal electrophoretic migration and low melting
temperature. The presence of endoplasmic reticulum (ER) enlargement due to mutant collagen retention in osteoblasts and
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fibroblasts of mutant fish was shown by electron and confocal microscopy. Two chemical chaperones, 4PBA and TUDCA,
were used to ameliorate the cellular stress and indeed 4PBA ameliorated bone mineralization in larvae and skeletal
deformities in adult, mainly acting on reducing ER cisternae size and favoring collagen secretion. In conclusion, our data
demonstrated that ER stress is a novel target to ameliorate OI phenotype; chemical chaperones such as 4PBA may be, alone
or in combination, a new class of molecules to be further investigated for OI treatment.
Introduction
Osteogenesis imperfecta (OI, OMIM # 166200, 166210, 259420,
166220) is a heritable skeletal disease mainly caused by domi-
nant mutations in COL1A1 or COL1A2 genes coding for the a1
and a2 chain of type I collagen, the most abundant component
of the bone organic matrix (1). Additional dominant and reces-
sive OI forms due to mutations in other genes have been de-
scribed, all affecting the synthesis, secretion, processing or
matrix incorporation of type I collagen or the osteoblasts differ-
entiation and activity, and all sharing the abnormal skeletal phe-
notype (2). Bone fragility, skeletal deformity and growth delay
were traditionally exclusively attributed to the presence of an al-
tered extracellular matrix. More recently, a role of abnormal os-
teoblasts homeostasis due to the mutant collagen retention and
affecting cell differentiation and activity has been hypothesized
as a relevant player in modulating OI pathophysiology, opening
new opportunities for the treatment of the disease (3,4).
A different ability to cope with intracellular stress modulates
the phenotypic outcome of the Brtl mouse, a well characterized
model for classical OI (3,5). Brtl carries in heterozygosis a typical
glycine substitution (G349C) in the a1(I) chain and, in presence
of the same causative mutation, shows either a lethal or a mod-
erately severe phenotype (6). In lethal mice an up-regulation of
molecules involved in apoptosis and protein degradation was
detected, whereas in mice with a moderately severe outcome
the up-regulation of chaperones was described (3,5). More re-
cently, we showed a different cytoskeletal assembly in lethal
Brtl cells; our data demonstrated that compromised cytoskeletal
organization impaired both cell signaling and cellular trafficking
specifically in mutant lethal mice, altering bone properties (7).
These results suggested that a disturbed intracellular homeo-
stasis in bone cells could modulate OI outcome. Indeed, osteo-
blast malfunctioning was reported to negatively affect bone
properties also in a different murine model for dominant OI, the
Amish mouse (Col1a2tm1Mcbr/J) carrying a G610C substitution in
the a2(I) chain (8,9).
Based on these observations, the targeting of osteoblast mal-
function, favoring either mutant collagen refolding and secretion
or its selective intracellular degradation, seems particularly at-
tractive to ameliorate OI outcome. No definitive therapy is so far
available for OI and the correction of the genetic defect by gene/
cell therapy approaches, although particularly appealing, will re-
quire long time and efforts. In the meantime, the search for novel
drugs able to improve the quality of life represents a strong pa-
tients’ demand. Furthermore, since cellular stress has been found
not only in classical dominant OI, but also in several novel reces-
sive OI forms due to mutations in protein affecting collagen post-
translational modifications, it may represent a common and
valuable target for multiple OI types. The availability of various
molecules already approved by Food and Drug Administration
(FDA) for other purposes and usable in a repositioning approach
will facilitate the transition from the bench to the bedsite, allow-
ing to skip pharmacokinetics tests and phase I safety trials (10).
Among the others, 4 phenylbutyrate (4PBA) and taurourso-
deoxycholic acid (TUDCA) are two well-known molecules
approved for urea cycle disorders and cholestasis respectively,
and known to have other functions (11–13). 4PBA is mainly an
ammonia scavenger, but it has also chaperone activity, since it
interacts with hydrophobic domains of misfolded proteins fa-
voring their folding (13). 4PBA also works as mild histone deace-
tylase inhibitor, promoting gene transcription (14).
TUDCA, the taurine conjugate form of ursodeoxycholic acid
(UDCA), is a soluble bile acid and its main effect as chemical
chaperone is based on improving protein folding capacity by ac-
tivation of the unfolded protein response (UPR) sensor activat-
ing transcription factor 6 and by assisting the trafficking of
mutant proteins. Furthermore, it inhibits the phosphorylation
of eIF2a, a target of the UPR sensor protein kinase RNA-like en-
doplasmic reticulum (ER) kinase, responsible for inhibition of
protein translation and apoptosis activation (15).
The in vivo evaluation of pharmacological treatments repre-
sents the most powerful and desirable approach in drug screen-
ing studies, since it allows consideration not only of the cell
specific effects of the compound, but also its absorption, organ
distribution, metabolism, excretion and toxicity in the whole or-
ganism. Of course, the availability of a valid model able to pro-
vide large dataset of results in short time and at low cost is a
fundamental prerequisite. Murine models do not seem to sat-
isfy such features due to the considerable effort required for
their generation and validation, housing space and cost,
amount of drugs necessary for the studies and number of ani-
mals to be sacrificed. Recently the small teleost Danio rerio stood
up as a better choice for drug screening trials (16). Danio rerio,
known as zebrafish, has been used extensively for genetic stud-
ies of vertebrate development due to its high fecundity, ex-
ternally fertilization and embryo transparency. These
characteristics, together with the high-quality genome se-
quence available (17,18), the generation of transgenic lines with
fluorescent proteins expressed under cell/tissue specific pro-
moters (19), the possibility to easily knock down genes by mor-
pholino (20) and to generate mutant lines with the CRISPR/Cas 9
editing system (21), strongly expanded zebrafish use for the in-
vestigation of human diseases. Indeed, large-scale mutagenesis
studies revealed that zebrafish reproduces many of the diseases
described in tetrapods, including those affecting the skeletal
system (22). Despite the evolutionary distance between humans
and teleosts, zebrafish shares 82% of disease associated targets
and a large number of drug metabolism pathways (17,23). In
particular, considering the skeletal system, the gene expression
profile associated with bone development is highly conserved
between tetrapods and zebrafish. Moreover, the types of ossifi-
cation, membranous and endochondral, as well as the presence
of all the bone cell types are common to zebrafish and humans
(24,25). Indeed multiple skeletal disorders have been recapitu-
lated in zebrafish, including both dominant and recessive OI
forms (22,26–29) and screening for anabolic bone compounds
was previously successfully accomplished (30).
The use of zebrafish as a cheap and convenient tool for drug
screening studies is further supported by the ability to administer
most drugs in a small volume of water without need for invasive
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procedures and to house zebrafish, at least in the larval stage, in
multi-well plates suited for high-throughput analysis and auto-
mated screening (11,30).
A zebrafish model for the classical form of OI, named
Chihuahua (Chi/þ), was discovered as a result of a large N-ethyl-
N-nitrosourea (ENU)-mutagenesis screening and identified by
an X-ray-based screening aimed at recognizing abnormal skele-
tal patterning. Chi/þ carries in heterozygosis a typical glycine
substitution (G574D, p.G736D) in the triple helical domain of the
a1 chain of type I collagen, the most common cause of classical
OI and revealed the bone outcome of severe human OI (22).
In the present study we performed the first deep investiga-
tion of Chi/þfish from larval to adult stage validating it as a
model for classical OI from a biochemical, morphological and
cellular point of view. We confirmed the intracellular retention
of mutant collagen causing ER enlargement in zebrafish and
succeeded in ameliorating the outcome of OI by administration
of 4PBA targeting osteoblasts malfunction.
Results
In order to use the zebrafish Chihuahua mutant for drug screen-
ing studies to discover novel OI therapies, a deep phenotypic
characterization of larval and adult mutant fish was performed.
Since OI is mainly associated with short stature, extreme bone
fragility and skeletal deformity, these parameters were first
investigated.
Adult Chi/þfish are shorter and show deformed and
fragile bones compared with WT
The growth of heterozygous Chi/þ and WT zebrafish was fol-
lowed from 2 to 40 weeks post-fertilization (wpf) by measuring
the standard length (SL) (Fig. 1A). Although Chi/þfish were
shorter than WT from 3 wpf, the difference was significant only
starting from 18 wpf (Chi/þ: 12.55 6 2.45 mm, n¼ 15; WT:
15.34 6 4.08 mm, n¼ 12; P¼ 0.04) and by 40 wpf the mutants
were 70% the size of the controls (P¼ 0.006) (Fig. 1B). The gross
Chi/þoutcome showed an abnormal body and head shape, thus
morphometric measurements were performed. The height at
anterior of anal fin (HAA), the distance from the snout to the
most posterior point of operculum (SOL) and the ventral to dor-
sal head height (HE) were evaluated (Fig. 1A). At 18 wpf HAA
was similar in Chi/þ and WT (2.82 6 0.85 mm, n¼ 15 and
3.05 6 0.95 mm, n¼ 12, respectively; P¼ 0.51), but the significant
lower SL/HAA ratio (Chi/þ: 4.60 6 0.58 and WT: 5.13 6 0.43;
P¼ 0.01) confirmed a more stocky body shape in mutants with
respect the WT. The SOL/HE ratio was also significantly smaller
in mutant fish (Chi/þ: 1.23 6 0.05 and WT: 1.33 6 0.09; P¼ 0.001)
supporting a more flattened head. By 19 wpf the SOL was
shorter in Chi/þ compared with WT (3.35 6 0.61 mm and
3.92 6 0.69 mm: P¼ 0.032).
The abnormal shape of the caudal fin, already described in
(22), gave rise to a lower ratio between the longest and shortest
tail axes in Chi/þ compared with control fish (Fig. 1C). The differ-
ence was detectable, although not significant, at 1 month post-
fertilization (mpf; Chi/þ: 1.50 6 0.05, n¼ 4; WT: 1.52 6 0.11, n¼ 10;
P¼ 0.66), but significance was reached at 2 mpf (Chi/þ:
1.64 6 0.14, n¼ 26; WT: 1.85 6 0.09, n¼ 27; P< 0.001).
Rib fractures and vertebral fusions were detected in adult
Chi/þfish by X-ray and confirmed by alcian blue/alizarin red
staining (Fig. 1D and E). The skeletal specific staining allowed
also a more detailed analysis of bone deformities. Vertebrae
were clearly misshapen, with altered and highly irregular post-
zygapophysis and prezygapophysis protrusions (Fig. 1E, ii). Ribs
appeared twisted and misshapen, with numerous calli indicat-
ing the healing of spontaneously occurring fractures (Fig. 1E, i).
Fin structure was seriously compromised as already reported by
Duran et al. (31), in particular the pelvic fins appeared atrophic
and twisted (Fig. 1E, iii and iv).
Also, the slope of the neural spine was altered in mutant fish.
The mean of the neural spine slope of the 10 precaudal vertebrae
(measured as described in Materials and Methods; Fig. 1E, ii) was
steeper in Chi/þ compared with WT fish starting from 1 mpf
(55.666 6.52 and 49.696 5.23, respectively; P< 0.001; n¼ 4 in
each group) and a significant difference was confirmed at 2 mpf
(Chi/þ: 57.576 6.64, n¼ 5; WT: 54.836 5.34, n¼ 4; P¼ 0.04).
A strong reduction of bone mineral density in mutant com-
pared with WT fish (n¼ 5 for each genotype and time point) was
demonstrated by mCT images performed at 3 mpf (Fig. 1F) and
10 mpf (data not shown).
In general, most of the analyzed parameters revealed a
worsening of the mutant phenotype with age.
Similar size but delay in mineralization characterized
Chi/þ larvae compared with WT
Starting from 5 days post-fertilization (dpf), the presence of a pro-
nounced fin fold bending already described by Fisher et al. (22)
distinguished Chi/þ from WT. The angle of the fin fold bending,
measured as described in Materials and Methods (Fig. 2A), was
significantly different between Chi/þ and WT (137.776 13.91,
n¼ 204 and 177.126 2.90, n¼ 217, respectively; P< 0.001).
Vital calcein labelling of 5 dpf fish revealed a delayed verte-
bral ossification. The notochord ossification began with the
third and fourth vertebral centra and spread as expected in the
two directions both in control (n¼ 78) and in Chi/þ (n¼ 96) fish
(Fig. 2B). Interestingly, while all WT larvae showed almost com-
plete ossification of the third, fourth and fifth centra (c3, c4, c5),
about 50% of the Chi/þ larvae showed no ossification of these
bones (Fig. 2C).
Alcian blue and alizarin red staining of 11 dpf larvae con-
firmed a significant mineralization delay in Chi/þ cranial bones
compared with WT (n¼ 50 and 65, respectively) (Fig. 2D). The
mineralization of 5th ceratobranchial (5CB), cleithrum (CL) and
notochord (NC) was considered as example of endochondral,
membranous and perichordal bone ossification, respectively.
Three classes of mineralization were identified, namely begin-
ning/no mineralization, incomplete and complete, based on the
level of alizarin red staining. A significant reduction of bone
mineralization was detected in mutant fish compared with WT
for 5CB (P¼ 0.003) and cleithrum (P¼ 0.007), the bones with min-
eralization type conserved in tetrapods. No difference was in-
stead present for notochord (P¼ 0.802) (Fig. 2E; Supplementary
Material, Table S1).
Type I collagen is overmodified in Chi/þ zebrafish
Acid soluble and pepsin digested type I collagen extracted from
skin, scales and bone of adult Chi/þ showed broader and slightly
slower bands of the a chains with respect to control fish in SDS-
PAGE, indicating the presence of collagen overmodification, a
typical OI feature (Fig. 3A).
We recently demonstrated that the normal type I collagen
melting temperature (Tm) in zebrafish is 35 C (32) Fig. S1, but
the Tm of Chi/þ skin and bone type I collagen determined by
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differential scanning calorimetry (DSC) showed a broad thermo-
gram. The deconvolution of the curve resulted in three peaks,
corresponding to a Tm of 35, 33 and 30 C (Fig. 3B;
Supplementary Material). Type I collagen melting temperature
lower than normal is caused by abnormal protein structure and,
based on these data, two populations of collagen molecules
containing mutant chains seemed to be present in Chi/þ to-
gether with normal collagen. Interestingly, from the peak inte-
gration, the mutant collagen molecules corresponded to  33%
of total collagen in bone (Fig. 3B) and 20–25% in skin (data not
shown). This implies that limited amount of mutant collagen
was incorporated in Chi/þ tissues.
Figure 1. Morphological characterization of adult (Chi/þ) zebrafish. (A) Morphometric parameters measured in adult fish. Standard length (SL) in red, height at anterior
of anal fin (HAA) in green, height at eye (HE) in blue, snout-operculum length (SOL) in yellow, major axes of the caudal fin in purple, minor axis of the caudal fin in pink.
(B) The growth curve shows that mutant fish (n¼15, grey triangles) are significantly smaller than WT (n¼12, black squares) from the 18th week post-fertilization (wpf).
SL: standard length. *P<0.05. (C) Representative image of WT and Chi/þ caudal fin. The caudal fin of mutant fish has less pronounced lobes than the WT fin. The dis-
tances measured as described in Materials and Methods are highlighted in red. Scale bar: 1 mm. (D) WT and Chi/þX-rays show severe alterations in the skeleton of mu-
tant fish. (E) Skeleton magnifications of 3 months old WT and Chi/þfish stained with alcian blue and alizarin red. Major and minor axes of the vertebral body and the
slope of the neural spine are indicated (ii). Deformed ribs with bone calli (i), fused vertebrae (ii, arrow), misshapen prezygapophysis and post-zygapophysis (ii, white
and black arrowheads), deformed pectoral (iii) and pelvic fins (iv) are evident in mutant fish. Scale bar: 500 mm. (F) mCT of 3 months old WT and Chi/þfish reveals the se-
vere under mineralization of mutant animals.
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Enlarged ER in Chi/þfish
One of the typical features in OI patients and murine model
type I collagen producing cells is the intracellular retention of
the mutant protein associated with an enlargement of the ER
cisternae and with cellular stress.
The easiest bone tissue to investigate in adult fish is repre-
sented by fin rays lepidotrichia, where it is relatively simple to
identify in histological sections osteoblast lining cells of the
hemi-rays. By transmission electron microscopy (TEM) we de-
tected a general enlargement of the ER cisternae in adult Chi/
þosteoblasts, absent in WT samples (n¼ 5 for each group)
(Fig. 3C).
The presence of enlarged ER cisternae in mutant fish was
also detected at embryo stage by injecting zebrafish embryos
with the mRNA coding for a yellow fluorescent protein (YFP) tar-
geting the ER. The percentage of embryos with strong intracellu-
lar fluorescent signal, supporting the presence of enlarged ER
cisternae, was clearly higher in Chi/þ (66.7%, n¼ 9) compared
with WT (16.7%, n¼ 12) fish (Fig. 3D).
Increased Hsp47 expression in Chi/þ compared with
control larvae
Hsp47 is a fibrillar collagen specific chaperone known to assist
procollagen assembly in the ER and its trafficking into the Golgi
(33,34). As specific antibodies for zebrafish Hsp47 were not avail-
able, a rabbit was immunized with recombinant zebrafish
Hsp47b lacking the ER retention signal. After affinity purifica-
tion, the polyclonal antibodies specifically detected zebrafish
Hsp47b (Supplementary Methods). Whole mount immunostain-
ing using Hsp47b antibody on 5 dpf Chi/þ (n¼ 38) and WT
(n¼ 36) larvae showed a stronger signal in mutant compared
with WT fish. A higher expression of Hsp47 in tail fin fold, skin
and intersomitic space was evident in Chi/þ compared with WT
(Fig. 3E; Supplementary Material, Table S2).
4PBA ameliorates bone mineralization defect in
Chi/þ larvae
The enlarged ER detected in mutant Chi/þ cells and the Hsp47
up-regulation prompted us to use the Chi/þmodel to target
in vivo cellular stress as possible novel OI therapy. The adminis-
tration of two different FDA approved molecules, 4PBA and
TUDCA, known to act also as chemical chaperones was at-
tempted. To determine the highest non-toxic dosage, toxicity
tests at increasing concentrations were performed first. Doses
of 0.05 mM for 4PBA and of 0.5 mM for TUDCA were chosen since
they corresponded to the highest drug concentrations associ-
ated to normal phenotype at the end of the toxicity test (data
not shown).
The period of treatment was selected based on the knowl-
edge that at 11 dpf the organogenesis is completed and mineral-
ization can be easily detected; furthermore, zebrafish can be
kept in 96-well/plate limiting the drug requirement.
At the end of the treatment the fin fold bending and the
mineralization level of 5CB, CL and NC in treated and untreated
Chi/þand WT zebrafish were evaluated.
4PBA significantly increased the fin fold angle in Chi/
þ (treated: 145.996 13.58, n¼ 192; placebo: 137.776 13.92,
n¼ 204; P< 0.001) (Fig. 4A). On the contrary, no significant effect
was evident after TUDCA treatment (treated: 134.376 22.16,
n¼ 130; placebo: 130.546 20.01, n¼ 118; P¼ 0.16), although af-
ter drug administration the caudal fin fold was slightly straight-
ened (Fig. 4E).
Figure 2. Skeletal evaluation of Chi/þ larvae. (A) Fin fold angle is represented in red in 11 dpf fish. Scale bar: 1 mm. (B) Representative images of 5 dpf larvae WT and Chi/
þ stained with calcein. The delay in vertebral centra ossification is evident. Scale bar: 250 mm. (C) Percentage of 11 dpf fish presenting calcein positive (mineralized) ver-
tebrae. c: vertebral centrum. Grey: WT; white: Chi/þ. (D) Alcian blue and alizarin red staining of WT and Chi/þ11 dpf larvae in ventral and lateral orientation. 5th cerato-
branchyal (5CB, arrowhead), cleithrum (CL, arrow) and notochord (NC, asterisk) are indicated. Scale bar: 200 mm. Delayed mineralization, represented by reduced
alizarin red staining, is evident in the mutant larvae. (E) Percentage of 11 dpf WT and Chi/þ larvae presenting distinctive levels of mineralization in the 5CB (i), the CL
(ii) and the NC (iii). White indicates beginning/no mineralization, grey indicates incomplete mineralization and black indicates complete mineralization.
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Regardless the difference between the genotypes, 4PBA ad-
ministration had a borderline significant effect on 5CB minerali-
zation (P¼ 0.07), determining an overall 10% increment of the
number of mineralized fish with respect the placebo group
(Fig. 4B; Supplementary Material, Table S3). The effect of the
treatment on 5CB mineralization was also explored within
genotypes. 4PBA increased the complete mineralization in
both WT and Chi/þwith respect untreated fish, but the statisti-
cal relevance was not achieved (Supplementary Material,
Table S4).
Similarly 4PBA significantly improved the mineralization of
the NC (P¼ 0.001) (Fig. 4D; Supplementary Material, Table S3).
This amelioration was evident in both genotypes, but the signif-
icance was detected only in WT (P¼ 0.002) (Supplementary
Material, Table S4).
No 4PBA effect was detected on CL mineralization classes
(P¼ 0.424) (Fig. 4C; Supplementary Material, Tables S3 and S4).
Mineralization analysis of treated and untreated mutant and
WT fish did not reveal any significant difference following the
TUDCA administration (Fig. 4F–H).
Figure 3. Biochemical and cellular evaluation of Chi/þ collagen type I. (A) SDS-PAGE of collagen type I extracted from skin, bone and scales of WT and Chi/þadult fish.
Mutant collagen is characterized by broader a bands (asterisks), indicating collagen type I overmodification. (B) Representative DSC thermogram of collagen extracted
from bone of Chi/þadult fish. The presence of three melting temperature (Tm) peaks is evident from the deconvolution analysis of the thermogram. Similar result was
obtained for collagen extracted from skin and scales (data not shown). (C) Transmission electron microscopy image of the caudal fin of WT and Chi/þadult fish. The en-
largement of endoplasmic reticulum (ER) cisternae is evident in mutant fish. N: nucleus; *: rough endoplasmic reticulum (ER). Magnification 12000X. (D) Confocal mi-
croscopy images of 24 hpf embryos WT and Chi/þ injected with mRNA expressing yellow fluorescent protein in the ER. A stronger signal in the mutant sample is
demonstrated. Magnification 40X, zoom 4X. (E) Whole mount immunohistochemistry of 5 dpf WT and Chi/þembryos using Hsp47b antibody. A stronger signal is evi-
dent in tail, skin and intersomitic space in mutant larvae. Arrow: intersomitic space, arrowhead: tail; asterisk: skin. Scale bar: 200 mm.
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Long-term 4PBA administration ameliorates skeletal
phenotype in adult Chi/þ
Based on the promising data obtained from the short term 4PBA
administration to Chi/þ larvae, mutant and WT fish were
treated from 1 dpf to 3.5 mpf (WT: placebo n¼ 18, treated n¼ 22;
Chi/þ: placebo n¼ 24, treated n¼ 21). SL, tail shape and neural
spine slope were evaluated at the end of the treatment.
The SL for both mutant and WT placebo was shorter than ex-
pected based on the growth curve values, in fact their size was
compatible with 11 wpf animals. This was likely due to growing
the zebrafish in bench tanks, the reduced water volume, the
less controlled temperature and the limited food administration
necessary to limit the water replacement. As expected a signifi-
cant difference was not detected in the placebo groups (Chi/þ:
10.40 6 1.70 mm; WT: 11.37 6 3.09 mm; P¼ 0.40), but 4PBA ad-
ministration increased the Chi/þ length to WT values
(11.36 6 2.11 mm and 11.55 6 2.75 mm, respectively; P¼ 0.77).
The treatment normalized the mutant tail shape. The ratio
between the longest and shortest tail axes (measured as re-
ported in Materials and Methods and described in Fig. 1A) was
significantly different in WT versus placebo mutant fish
(1.77 6 0.14 and 1.55 6 0.10, respectively; P< 0.001), but it was in-
creased in Chi/þafter 4PBA treatment (Chi/þ: 1.73 6 0.25;
P¼ 0.08), approaching the WT value (Fig. 5A).
The 4PBA also improved the morphology of the mutant skel-
eton. The slope of the neural spine in the precaudal vertebrae
following drug administration was significantly reduced with
respect untreated mutant fish (50.696 7.86 and 53.066 8.19,
respectively; P¼ 0.002), reaching the WT untreated value
(49.786 6.10) (Fig. 5B). The comparison performed on the sin-
gle vertebral centra revealed that the most significant reduction
of the slope was detected on the more caudal vertebrae ana-
lyzed (Supplementary Material, Table S5).
Mean vertebrae length and area were also increased signifi-
cantly in Chi/þ treated compared with the placebo group
(length: 0.26 6 0.06 mm and 0.22 6 0.04 mm; P¼ 0.04; area:
0.045 6 0.02 mm2 and 0.034 6 0.02 mm2; P¼ 0.047).
4PBA treatment reduced ER cisternae size and increased
the amount of extracellular collagen
In order to understand the mechanism of 4PBA in ameliorating
the skeletal phenotype of Chi/þfish, TEM of 11 dpf 4PBA treated
embryos was performed to investigate the ER cisternae size.
Electron microscopy images revealed the presence of normal ER
cisternae in treated Chi/þ, although they were still coexisting
with cisternae of enlarged size (Fig. 5C).
Whole mount immunostaining of 5 dpf treated and placebo
Chi/þfish using Hsp47b antibody did not show any reduction in
the expression of this type I collagen specific chaperone, that re-
mains up regulated in mutant fish after treatment
(Supplementary Material, Table S2).
Interestingly, more type I collagen was detected in mutant
fish following 4PBA treatment, supporting an amelioration of its
secretion. No such effect was detected following TUDCA admin-
istration. Taking advantage of the regenerative property of
zebrafish tail, about half of adult Chi/þfish tail was cut and the
secreted and newly deposited collagen was evaluated in ab-
sence or presence of 4PBA (n¼ 3 and 4, respectively) or TUDCA
(n¼ 4 in each group) after 7 days. The higher percentage of fluo-
rescent green signal in the regrown tails of 4PBA treated Chi/
þ zebrafish under polarized light after staining with picro sirius
red clearly demonstrated an increased amount of collagen in
the secreted matrix (Fig. 5D; Supplementary Material, Table S6).
This increase was undetectable upon TUDCA administration
(Supplementary Material, Table S7).
4PBA did not affect early and late osteoblast-specific
genes expression
To evaluate if the inhibitory effect of 4PBA on class I and II his-
tone deacetylases was affecting the transcription of bone form-
ing cells specific genes, the expression of an early (sp7) and two
late (col1a1a and bglap) osteoblast genes was evaluated by qPCR
after 7 days of treatment in WT and Chi/þ larvae. No difference
Figure 4. Effect of 4PBA and TUDCA treatment on Chi/þ larvae. The caudal fin fold angle of 11 dpf Chi/þ larvae increased after treatment with both 4PBA (A) and TUDCA
(E), but only 4PBA determined a significant straightening. *P<0.001. The administration of 4PBA increased the mineralization level of the 5CB (B), CL (C) and NC (D) in
mutant larvae. The treatment with TUDCA was ineffective in increasing the mineralization of all evaluated bones (CB, F; CL, G and NC, H) both in WT and in Chi/þ lar-
vae. In (B)–(D) and (F)–(H), white boxes indicate beginning/no mineralization, grey boxes incomplete mineralization and black boxes complete mineralization.
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was detected for all of the three genes (Supplementary Material,
Fig. S2A–C).
Western blot analysis using an antibody against acetylated-
H3 did not reveal any significant difference in its expression fol-
lowing 0.05 mM 4PBA treatment in tissue lysates from larvae
and adult fish (Supplementary Material, Fig. S2D and E), indicat-
ing that the inhibitory effect of 4PBA on histone deacetylases
was not significant at the used concentration.
Discussion
With the ultimate aim to develop and validate a high through-
put drug screening tool to find novel cure for the untreatable
brittle bone disease OI, our study accomplished three major
findings. First, the mutant zebrafish Chihuahua (Chi/þ) was vali-
dated as model for classical OI by deep biochemical, morpho-
metric and cellular characterization. Second, the power and
advantages of this model for drug screening both in larvae and
in adult were highlighted by defining easily traceable output.
Finally, by a candidate approach 4PBA was identified to have po-
tential to treat OI most likely based on its chaperone activity.
Chihuahua mirrored morphological, biochemical and
cellular OI outcome
Short stature is a main hallmark for OI patients and small size
is a common feature in OI murine models (2,6,8,35,36). The
growth curve analysis performed from 2 to 40 wpf confirmed in
Chi/þa growth delay together with a more stocky body and
head shape compared with WT.
The two main biochemical properties of OI mutant type I
collagen are excessive post-translational modification and re-
duced thermal stability due to altered structure (37,38). A slower
and broader electrophoretic migration of a bands in type I colla-
gen extracted from different Chi/þ tissues supported the pres-
ence of overhydroxylated and overglycosylated protein also in
this model. Furthermore, the Tm of type I collagen in mutant
Chi/þwas reduced. The DSC thermogram showed, together with
the expected peak at 35 C corresponding to the fraction of col-
lagen molecules containing only normal a chains (32), two lower
Tm peaks at 33 and 30 C suggesting the presence of at least
two different populations of collagen molecules with mutant
(a1G574D) chains. In zebrafish, type I collagen may contain not
only a1 and a2 chains, but also a third chain, namely a3, which
is encoded by the col1a1b gene and absent in tetrapods (32,39).
We recently proposed the presence of an equimolar amount of
the three a chains in zebrafish type I collagen, leaving open the
possibility of the existence of a1a3a2 alone or the presence of
equal amounts of a1a1a2 and a3a3a2 or a combination of the
three trimers (32).
Since only a single DSC peak with Tm 35 C was observed in
wild-type fish (Supplementary Material, Fig. S1), the additional
DSC peaks of Chi/þbone collagen with Tm 33 C and Tm 30 C
(Fig. 3B) likely represent the molecules with one and two a1G574D
chains, respectively (38). Based on our previous findings on zebra-
fish type I stoichiometry (32) the presence of a1G574Da1G574Da2 tri-
mers suggests that zebrafish collagen contains either all three
Figure 5. 4PBA treatment ameliorated the tail shape (A) and normalized the neural spine slope (B) of Chi/þfish after 14 weeks of treatment. Scale bar: 1 mm in (A) and
500 mm in (B). (C) Transmission electron microscopy of 11 dpf Chi/þ larvae showed a general reduction of the ER cisternae size after 4PBA treatment. Magnification
12000X. (D) Representative images of picro sirius red staining Chi/þ zebrafish regrown tail after 7 days from tail clipping in absence or presence of 4PBA. A strongest sig-
nal in the sample obtained from 4PBA treated fish confirmed a higher amount of collagen in the matrix following 4PBA treatment. White lines indicate the portion of
tail regrown in 7 days. Magnification 10X.
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possible trimers or just a1a1a2 and a3a3a2, but not a1a3a2 alone.
The observation of 33% mutant molecules in bone (Fig. 3B) and
<25% mutant molecules in skin (data not shown), which are val-
ues lower than expected based on the proposed stoichiometry
(Supplementary Material, Table S8), indicated either a low matrix
incorporation for the mutant collagen or its partial intracellular
retention.
Indeed enlargement of ER in Chi/þmutant fish was demon-
strated in fibroblasts by confocal microscopy and in osteoblasts
by electron microscopy. Intracellular retention of mutant colla-
gen has been widely demonstrated both in vitro and in vivo in OI
patients and in murine models (35,40). The size of the ER corre-
lates with the unfolded protein load and ER expansion is ex-
pected in presence of excessive misfolded proteins and it is
normally associated to cellular stress.
Finally, whole mount immunohistochemistry on 5 dpf WT
and mutant zebrafish revealed a strong Hsp47 signal in Chi/þ in
the skin, in the space among somites and in the tail fin. An in-
creased Hsp47 expression either at transcript or protein level, as
well as an increased intracellular colocalization with mutant
type I collagen, were reported in cells from OI patients and mu-
rine models (9,41). Hsp47 is an ER chaperone known to play a
role in collagen synthesis by stabilizing the procollagen mole-
cules. Hsp47 also facilitates type I collagen transfer from the ER
to the Golgi compartment (33,34). An increased expression of
Hsp47 in cells expressing structurally abnormal type I collagen
may either represent an attempt to favor its proper synthesis
and secretion and/or the impossibility for the mutant collagen
to move properly throughout the secretory pathway.
Chihuahua: a zebrafish reproducing bone OI phenotype
mCT, X-ray and skeletal-specific staining confirmed the bone de-
formity and multiple rib fractures seen in adults Chi/þ zebrafish
as originally reported (22), but also provided novel insight vali-
dating Chi/þas good model for human OI. Furthermore, several
vertebral compressions were identified both in abdominal and
in caudal regions. Vertebral compressions associated with ver-
tebral fractures are described in human OI and are mainly con-
sequences of poor quality of bones that are unable to sustain
the mechanical loading. Interestingly, none of the OI murine
models reproduced the vertebral phenotype, mainly because ro-
dents, as quadrupeds, have a structure of spine and center of
gravity quite different from humans. Zebrafish instead bear
cranial-to caudal spinal loads that are originated by swimming
forward through water coupled with caudal propulsion and that
are quite comparable to the gravitational load to which humans
are subjected. Overall, the similar biomechanical forces along
the spine seem to make fish more susceptible to vertebral dam-
age (42) and thus a better model for mimicking human spine
defects.
Vertebrae distortion was also detected in mutant fish, as
demonstrated by a steeper slope of the neural spines compared
with WT. The presence of mutant collagen in Chi/þ could be re-
sponsible for the deformity, since neural and haemal appendi-
ces are intramembranous bones and the lack of cartilage anlage
underlines a relevant role for type I collagen in shape and min-
eralization of these structures (43).
Duran et al. described the presence of abnormal actinotrichia
and lepidotrichia shape and length during fin development and
regeneration in Chi/þ zebrafish (44). Actinotrichia are the first
fin skeletal structures formed during development and they
represent a support and a scaffold for the migration of
mesenchymal stem cells responsible for the generation of the
fin fold connective tissue (45,46). They consist of collagen fibrils
mainly composed of a specific type of collagen II and of homo-
trimeric collagen I. The presence of abnormal actinotrichia in
Chi/þ zebrafish underlined the importance of structurally cor-
rect collagen molecules for proper fin formation.
The significant reduction of the ratio between long- and
short-tail axes in Chi/þadults allowed us to quantify this abnor-
mality originally reported by Fisher (22).
A significantly less acute angle of the Chi/þ larvae fin fold
compared with WT was detected. It is interesting to notice that
up to 3 dpf col1a1a, encoding for the a1 chain of type I collagen,
is the only type I collagen coding gene that is expressed in the
fin fold (31). Therefore, the change in the angle may either be
the consequence of the presence of mutant protein and/or its
reduced amount due to possible intracellular retention as dis-
cussed in following sections.
Of note, although no size difference could be detected at lar-
val stage in mutant Chi/þ compared with WT, as previously re-
ported, a delay of mineralization was detected at the level of 5th
ceratobranchial, cleithrum and notochord tip, examples of en-
dochondral, membranous and perichordal bones. Delayed min-
eralization is another common feature in OI, reported for
several OI murine models (47) and is known to affect both mem-
branous and endochondral bones (48).
4PBA administration ameliorated the bone phenotype
in Chi/þ larvae and adults acting mainly as chemical
chaperone
A definitive cure for OI will require the correction of the genetic
defect, and although gene therapy approaches are under inves-
tigation, the bench to bed transition of such strategies is far in
time (49–51). In the last years drug repositioning approach dem-
onstrated to be an elective choice for disease treatment based
on economic and timing reasons and it is definitely appealing
for rare disorders (10). The identification of curative effect of
molecules already approved by FDA will bypass at least some of
the more expensive and time consuming phases for drugs
development.
The availability of a validated zebrafish model for classical
OI motivated our study on this direction.
Based on recent findings, the outcome of OI and of other
skeletal disorders associated with misfolded structural proteins
partially retained inside the cells is not only due to abnormal
extracellular matrix, but also to altered cellular homeostasis.
Thus, targeting cellular stress could represent a valid approach
to ameliorate the disease phenotype (52–54).
For our study, we treated the OI zebrafish model Chi/þwith
4PBA and TUDCA, already approved by the FDA for urea cycle
disorders and cholestasis respectively and known to have chap-
erone activity (11,12). Their administration was facilitated by
the fact that they are water soluble molecules.
Only 4PBA significantly improved straightening of the fin
fold in mutant larvae and rescued the mineralization delay in
Chi/þ zebrafish. Although significant values were not always
reached, a clear tendency to higher mineralization was detected
in 5CB and NC of treated WT and mutant fish. Furthermore, a
long-term treatment with 4PBA from 1 dpf to 3.5 mpf resulted in
an amelioration of growth, vertebral shape and tail symmetry.
We first evaluated the effect of the drugs at larval stage tak-
ing advantage of the small amount of the required drug and the
space for husbandry. For the evaluation of drug efficacy, the fin
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fold bending characteristic of the Chi/þmodel, most likely asso-
ciated to the presence of mutant type I collagen, was first deter-
mined. The small fin fold phenotype and/or abnormal tail shape
is a common feature in various zebrafish models of skeletal dis-
eases caused either by the absence or the presence of mutant
structural proteins (44,55,56). The most abundant structural ele-
ments in the early fin fold and in the distal region of adult tail
are actinotrichia, structures containing both collagen I and col-
lagen II (31). Collagen IX is known to interact with collagen II
and to have a role in vascular plexus formation in caudal fins.
A mutation in col9a1 is present in the persistent plexus (prp)
zebrafish mutant. Interestingly, overexpression of col9a1 in prp
ameliorates the fin fold phenotype, supporting the idea that
also increasing the amount of structurally abnormal protein in
extracellular matrix may lead to an amelioration of the pheno-
type (56). This is reminiscent to what was observed in OI pa-
tients and murine models following bisphosphonate treatment,
leading to reduced bone turnover and consequently to an in-
crease of collagen I content in the bone matrix.
Type I collagen is the major organic component of bone and
its amount is strictly linked to bone mineral density (57). Using
TEM analysis in zebrafish larvae and a tail fin regeneration as-
say in adults we demonstrated that the amelioration of the
bone phenotype in Chi/þafter administration of 4PBA is caused
by an increase of collagen secretion associated to a reduction of
ER cisternae size due to the chaperone function of the drug.
TEM showed a partial rescue of the ER cisternae enlargement,
showing a prevalence of normal size cisternae in larvae grown
in the presence of 4PBA and picro sirius red staining of the
regenerated tail in 4PBA treated mutant fish revealed an in-
crease in collagen amount.
The intracellular collagen folding requires specialized chap-
erones (i.e. PDI, FKBP65, HSP47) (58) and it seems unlikely that
the small 4PBA molecule could mimic such a complex group of
proteins. It may be possible that 4PBA interacts with hydropho-
bic unfolded regions of the triple helix and limits the intracellu-
lar aggregation of mutant collagen favoring its secretion and
maybe limiting its degradation (59,60). However, we cannot ex-
clude that 4PBA acts intracellularly on non-collagenous proteins
whose folding and secretion may be compromised by the flood-
ing of the ER.
Since 4PBA is also known to act as a mild inhibitor of histone
deacetylase, such a role was further investigated.
The culture of osteoblasts in the presence of Na-butyrate was
reported to increase histone acetylation, to stimulate cell prolifer-
ation, and to promote osteoblast maturation by favoring Runx2
expression (61). The presence of Na-butyrate stimulated alkaline
phosphatase activity in murine calvarial organ cultures (62).
To date little in vivo data exist that suggest a dose depen-
dency of 4PBA for the inhibition of histone deacetylase and/or
its chaperone function. Luo et al. demonstrated that intraperito-
neal injection of 4PBA 20 mg/kg/day for 4 weeks was enough to
attenuate ER stress in a murine model of myocardia hypertro-
phy, whereas a 100 mg/kg/day was necessary to inhibit his-
tone deacetylases (63). On the other hand, a single injection of
10 mg/Kg was sufficient to protect mice from radiation preserv-
ing histone H4 acetylation (64).
Based on existing in vitro and in vivo data and considering
that, at least for some drugs the micromolar doses in zebrafish
are comparable to milligrams per kilograms in mice (65), the
4PBA concentration used in our study should not significantly
inhibit histone deacetylase activity.
Indeed distinct difference in expression of acetylated his-
tone 3 was not detected at protein level in 11 dpf 4PBA treated
larvae as well as in tail extracts from adult treated zebrafish.
Similarly, no difference in the transcription of bone markers
was detected by qPCR.
The lack of effect following TUDCA administration is not un-
expected. The two molecules are chemically different and they
can act in different ways, as already reported (66,67).
Furthermore, we cannot exclude a yet unknown contribution of
4PBA for bone homeostasis.
In conclusion, we reported a comprehensive investigation of
the Chi/þ zebrafish OI model validating it as a powerful tool for
study OI pathophysiology. We identified peculiar phenotypic
outcomes that could be easily used as tools to validate the effi-
ciency of molecules in high throughput drug screening tests.
4PBA was demonstrated to be a promising candidate for OI due
to its chaperone activity.
Materials and Methods
Husbandry
Wild-type AB (WT) and heterozygous Chihuahua (col1a1adc124/þ,
Chi/þ) zebrafish arise from natural spawning or from in vitro fertil-
ization. The mutant Chi/þ, provided by Professor Shannon Fisher
(Dept of Pharmacology & Experimental Therapeutics, Boston
University School of Medicine, USA), carries a G2207A mutation
in col1a1a, causing a p.G736D (G574D) substitution in the a1 chain
of type I collagen. Embryos were kept in Petri dishes in fish water
(NaHCO3 1.2 mM, instant ocean 0.1 g/L, CaSO4 1.4 mM, methylene
blue 0.00002% w/v) at 28 C until 6 day post-fertilization (dpf),
then housed in ZebTEC semi-closed recirculation housing sys-
tems (Tecniplast) and kept at a constant temperature (27–28 C),
pH (7.5) and conductivity (500 lS) on a 14/10 light/dark cycle. For
the experiments stated below larvae and adult fish were anesthe-
tized using a solution of tricaine (3-amino benzoic acidethylester,
Sigma Aldrich) 0.0016% w/v, in fish water and sacrificed by tri-
caine overdose (0.03% w/v). All experiments were performed in
accordance with the approved guidelines, in agreement with EU
Directive 2010/63/EU for animals. The experimental protocol was
approved by the Italian Ministry of Health (Approval Animal
Protocol No. 1/2013).
Genotyping
Depending on the experiment type, DNA was extracted from sin-
gle embryos, pool of embryos or caudal fin biopsies from adult
zebrafish. Tissues were lysed in Tris–HCl 100 mM, pH 8.5, EDTA
5 mM, SDS 0.2% w/v, NaCl 200 mM and proteinase K (Sigma
Aldrich) 2.5 mg/ml, for at least 3 h at 55 C. DNA was precipitated
with isopropanol and dissolved in Tris–HCl 20 mM, EDTA 1 mM,
pH 8.0. The Chi/þ genotype was evaluated by PCR amplification of
col1a1a (NC_007114.6) followed by restriction enzyme digestion.
The following primers were used: sense 5’-TCTTAAGGGT
GACAGAGTGAGTATGAC-3’ (23101253–23101279) and reverse
5’-CAACTTCAAGATGTTTCATCACTTAGTATG-3’ (23101543–2310
1514). Since the mutation creates a novel BtsCI restriction site,
the amplicon was digested with this enzyme (New England
Biolabs) and the products separated on 2% agarose gel. A single
290 bp band revealed the presence of the WT allele, while the mu-
tant allele generated 141 and 149 bp fragments.
Morphometric evaluation
Zebrafish were anesthetized with tricaine and images were ac-
quired with a Leica M165 FC microscope (Leica) connected to a
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Leica DFC425 C digital camera (Leica). Measurements were per-
formed using the Leica LAS v4.5 software (Leica).
The fin fold angle was measured on dorsal images of 11 dpf
zebrafish as the angle between the notochord axis and the line
connecting the posterior tip of the notochord and the terminal
end of the fin (Fig. 1A).
Using lateral images of embryos and adult fish the following
parameters were measured: SL, defined as the distance from
the snout to the caudal peduncle or, in pre-flexion larvae that
do not have a caudal peduncle, to the posterior tip of the noto-
chord; HAA, defined as the distance from ventral to dorsal, mea-
sured immediately anteriorly to the anal fin and
perpendicularly to the axis defined by SL; Snout-Operculum
Length (SOL), defined as the distance from snout to the most
posterior point of operculum; height at eye (HE), defined as the
distance from ventral to dorsal, measured immediately posteri-
orly to the eye and perpendicularly to the axis defined by SL (68)
(Fig. 1A). The symmetry of the tail was evaluated as the ratio be-
tween the mean of the two major axes (defined as the distance
between the central part of the caudal peduncle and the tip of
each caudal lobe) and the minor axis (the distance between the
central part of the caudal peduncle and the conjunction point of
the two caudal lobes) of the tail (Fig. 1A and C).
The shape and the size of vertebrae were evaluated on im-
ages of adult fish stained with alcian blue and alizarin red ac-
quired on lateral orientation. For the dimension, the major and
the minor axis of each vertebra were defined respectively as
the mean of the length measured dorsally and ventrally and as
the mean of the height measured anteriorly and posteriorly to
the vertebral centrum (Fig. 1E, ii). The slope of the neural spine
is measured as the angle between the major axis and the line
connecting the edge of the spine with the most anterodorsal re-
gion of the centrum (Fig. 1E, ii). The first 10 vertebrae articulated
with the ribs were considered.
Growth curve determination
WT and Chi/þ zebrafish were collected from in vitro fertilization
and genotyped at 6 dpf based on the caudal fin fold curvature.
Lateral images of each fish were acquired every week from 11
until 137 dpf and at 280 dpf. SL was measured as described
above.
X-ray
X-rays of adult 3.5 months old fish were acquired with a
Faxitron Mx-20 (Faxitron), using 25 kV for 10 s. The Kodak
DirectView Elite CR System and k-Pacs software (Kodak) were
used.
lCT
WT and Chi/þ zebrafish at 3 (n¼ 5 and 6, respectively) and 10
mpf (n¼ 5 for both genotype) were sacrificed, fixed overnight at
4 C in paraformaldehyde (PFA) 4% (w/v) and stored in ethanol
75% v/v. For lCT fish were placed in a radiotranslucent sample-
holder, foam pads were applied to prevent shifting during the
scan process and the specimens were scanned with a mCT 40
desktop cone-beam lCT (Scanco Medical) using a voxel size of
10 mm with 1000 projections per slice at a tube energy of 55 kV
with an intensity of 145 mA. Reconstructed slices were seg-
mented using the script ‘UCT_EVALUATIONV6’ of the Scanco
MicroCT software suite with the following parameters:
sigma¼ 0.8; support¼ 1; lower¼ 165–185; upper¼ 1000; unit¼ 6.
The lower threshold was varied between 165 and 185 to provide
the optimal signal/noise ratio for each sample. Three-dimen-
sional reconstructions were imaged using the program mCT Ray
V3.8 of the Scanco MicroCT software suite.
Skeletal staining
Cartilage and bone were stained with alcian blue and alizarin
red using a protocol modified from Walker et al. (69). Both larval
and adult WT and Chi/þ zebrafish were sacrificed and fixed
overnight in PFA 4% w/v in PBS (Sigma Aldrich) with CaCl2
0.9 mM and MgCl2 0.49 mM, pH 7.4 at 4 C. Scales and internal or-
gans were manually removed from adults, and fat was elimi-
nated by an overnight bath in acetone. Embryos and adult fish
were stained overnight at room temperature (RT) with a solu-
tion of alcian blue 8GX (Sigma Aldrich) 0.02% w/v, ethanol 70%
v/v, MgCl2 80 mM and then rehydrated in a series of ethanol (80,
50, 25%), in Tris–HCl 100 mM, pH 7.5, MgCl2 10 mM, 5 min each.
Bleaching to eliminate the pigmentation was performed with
H2O2 3% v/v, KOH 0.5% w/v at RT and followed by two washes in
glycerol 25% v/v, KOH 0.1% w/v. Soft tissues were digested with
1 mg/ml (for larvae) or 10 mg/ml (for adult fish) trypsin dissolved
in a 30% v/v, solution of saturated B4Na2O7 for a time depending
on fish size. After the staining in alizarin red S (Sigma Aldrich)
0.01% w/v, glycerol 25% v/v, Tris–HCl 100 mM, pH 7.5 overnight
at RT, fish were washed in increasing glycerol/KOH 0.1% series
(50%, 80%) and finally stored at 4 C in glycerol 100%, KOH 0.1%.
Images were acquired using a Leica M165 FC microscope con-
nected to a Leica DFC425 C digital camera. The mineralization
of the 5th ceratobranchial, the notochord and the cleithrum was
evaluated. Three operators blinded to the genotype of the fish
qualitatively described the level of ossification of these bones
for each embryo as beginning/no ossification, intermediate ossi-
fication or complete ossification independently.
Calcein (C30H26N2O13, Sigma Aldrich) was used as vital dye to
stain calcified bones. WT and Chi/þ 5 dpf zebrafish were trans-
ferred to a physiologic solution (NaCl 0.9% w/v, pH 7.5) contain-
ing calcein 0.2% w/v for 20 min, washed with fish water until
water was clean and kept in clear water overnight. The day after
animals were anesthetized with tricaine and mounted in meth-
ylcellulose (Sigma Aldrich) 3% w/v. Fish images were acquired
as previously described using a GFP filter. Three operators
blinded to the genotype of the fish evaluated the ossification of
the centra independently.
Type I collagen analysis
Bones (vertebrae, ribs and head bones), scales and skin were
dissected from adult mutant and WT fish following sacrifice.
The tissues were defatted for 6 h in NaOH 0.1 N at 4 C. The
scales and bones were decalcified for 48 h in EDTA 0.5 M pH 7.4
at 4 C. The acid-soluble type I collagen (ASC) was obtained by
protein extraction in acetic acid 0.5 M at 4 C for 48 h. The ASC
was then precipitated by NaCl 0.9 M in acetic acid 0.5 M. The
pepsin-soluble fraction (PSC) was obtained by further digestion
of the pellet obtained from the acetic acid extraction with pep-
sin 0.1 mg/ml in acetic acid 0.5 M at 4 C for 48 h. The PSC was
precipitated by NaCl 0.9 M in acetic acid 0.5 M overnight at 4 C.
Both ACS and PSC fractions were quantified by measuring the
4-hydroxyproline amount after acid hydrolysis. The purified
collagen was analyzed on 6% polyacrylamide gel electrophore-
sis (SDS-PAGE) in the presence of urea 0.5 M. The gels were
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stained overnight with picric acid 0.08 M, Coomassie Brilliant
Blue R250 (Sigma Aldrich) 0.04% w/v destained in tap water and
acquired with Versadoc3000 (BIO-RAD).
Differential scanning calorimetry
DSC thermograms of collagen solutions in HCl 2 mM, pH
2.7 were recorded in an N-DSC III differential scanning calorim-
eter (Calorimetry Sciences Corporation) at 0.25 C/min heating
rate.
Transmission electron microscopy
Following anesthesia in 0.0016% tricaine the caudal fin biopsies
were obtained from adult WT and Chi/þ fish and rapidly trans-
ferred in Karnowsky fixative (sodium cacodylate 0.1 M, pH 7.8,
glutaraldehyde 1.5% v/v, paraformaldehyde 4% w/v) overnight
at 4 C. Samples were then decalcified in EDTA 14% w/v pH 7.1
at 4 C, for 24 h for Chi/þand 48 h for WT. Chi/þ11 dpf embryos
treated with placebo or 4PBA were sacrificed with 0.03% tricaine
and fixed with Karnowsky fixative overnight at 4 C. The sam-
ples were then post-fixed in OsO4 2% w/v in H2O for 2 h at RT,
rinsed in distilled water and dehydrated in ethanol. The speci-
mens were infiltrated with LR White acrylic resin overnight at
4 C and polymerized in gelatin capsules at 60 C for 24 h. Thin
sections (60–70 nm thick) were cut on a Reichert OM-U3 ultrami-
crotome with a diamond blade and collected on 300-mesh
nickel grids. The grids were finally stained with saturated acqu-
eous uranyl acetate followed by lead citrate and observed with a
Zeiss EM900 electron microscope, operated at 80 kV with an ob-
jective aperture of 30 mm.
Confocal analysis of embryos
The ER-YFP vector (by courtesy of Yung-Yao Lin of the
Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK)
which encodes a fluorescent fusion protein carrying calreticulin
ER targeting and lysine–aspartate–glutamate–leucine retrieval
sequences was used to analyze ER morphology (70). The mRNA
was in vitro transcribed from the linearized construct using the
mMACHINE mMESSAGE kit (Ambion) according to the supplier’s
instructions. The RNA integrity was verified on denaturing 1%
agarose gel and the RNA clean-up and concentration was per-
formed using the RNeasy MiniElute Cleanup kit (QIAGEN). The
ER-YFP RNA was microinjected into embryos at the stage of 2–4
cells, using 300 pg of RNA and dextran conjugated with Alexa
647 (Molecular Probes) 0.05% w/v as tracer in a total volume of
4 nL for each injection. Microinjection was carried out using an
InjectMan micromanipulator (Eppendorf) assembled on a Leica
M165 FC stereomicroscope. At 24 hpf, the chorion was manually
removed and the embryos fixed in PFA 4% w/v overnight at 4 C.
The samples were permeabilized with PBS containing Triton X-
100 (BDH Chemicals) 0.1% v/v, in ice for 10 min, and stained
with 4’,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich)
100 ng/ml for 30 min. The embryos were cut in half: the tail was
mounted on a cover slip in 30 lL of 1% low melting agarose at
60 C to be analyzed at confocal microscopy (TCS SP2-Leica),
while the head was used for genotyping. The fluorescence in-
tensity was qualitatively evaluated by three independent opera-
tors blinded to the fish genotype. The results were expressed as
percentage of fish with brighter signal.
Picro sirius red collagen staining
The caudal fin of adult Chi/þ zebrafish was cut and either
treated with 4PBA (n¼ 4), or TUDCA (n¼ 4) or with placebo (n¼ 3
for 4PBA experiment, n¼ 4 for TUDCA experiment) for 7 days.
Then, the regrown caudal fins were cut again and fixed over-
night in PFA 4% w/v in PBS. Tails were stained 1 h in Sirius Red
0.1% w/v (Direct Red 80, Sigma Aldrich) in saturated aqueous so-
lution of picric acid (Sigma Aldrich). After the staining tails were
washed in acetic acid 0.5% v/v, and directly dehydrated three
times in absolute ethanol. Samples were clarified with xylene
and mounted with DPX (Sigma Aldrich). Slides were observed
under polarized light with the LEICA DM2500 microscope (Leica)
and acquired using the LEICA ICC50 W digital camera (Leica).
The analysis of the total and the green area were performed us-
ing Leica LAS4.5 software.
Whole mount immunostaining
4PBA treated (WT n¼ 26, Chi/þn¼ 24) and untreated (WT n¼ 36,
Chi/þn¼ 38) zebrafish embryos were collected at 5 dpf, fixed
overnight in PFA 4% w/v in PBS., washed in PBS and permeabi-
lized overnight in methanol at 20 C. Samples were hydrated
with ethanol (100, 80, 70, 50, 0%) in PBS and digested with pro-
teinase K 0.1% w/v in PBS at 25 C for 15 min and hyaluronidase
2% w/v in PBS at 25 C for 20 min. Embryos were fixed in PFA 4%
for 30 min and PFA was eliminated by incubating samples with
NH4Cl 50 mM in PBS, for 1 h at RT. To block endogenous peroxi-
dase activity embryos were incubated with bovine serum albu-
min (BSA, Sigma Aldrich) 0.5% w/v and H2O2 0.5% v/v, for 30 min
at RT. After a 5 min wash with PBS, Tween-20 0.05% v/v (Sigma
Aldrich) (PBS-T), blocking solution (BSA 5% w/v in PBS-T) was
added for 2 h at RT. Hsp47b affinity purified antibody (1:1000 in
5% BSA/PBS-T) and anti-rabbit secondary antibody (1:200 in 1%
BSA/PBS-T) were used. DAB substrate (Thermo Scientific) was fi-
nally added until appearance of the staining. Fish were incu-
bated in increasing glycerol series (50%, 80%) and finally stored
at 4 C in glycerol 100%. Images were acquired using a Leica
M165 FC microscope connected to a Leica DFC425 C digital cam-
era. Three operators blinded to the genotype and the treatment
of the fish evaluated presence or absence of the signal
independently.
Drug toxicity test
Toxicity tests were performed to determine the relevant drug
dosage. WT embryos (10 per group) were manually dechorio-
nated at 24 hpf and treated from 1 to 7 dpf with different con-
centrations of the drug dissolved in fish water (0.05, 0.1, 0.5, 1, 5
and 10 mM for 4PBA (Sigma Aldrich), and 0.05, 0.1, 0.2, 0.5 and
1 mM for TUDCA (Sigma Aldrich) or with placebo in 96-well
plates, using 200 ll per fish. Half of the volume was replaced
with fresh solution every day. The number of surviving and the
number of misshaped zebrafish were evaluated at the end of
the treatment, in order to define the highest concentration
without visible side effects.
Drug treatment
WT and Chi/þ embryos were obtained by in vitro fertilization,
manually dechorionated at 24 hpf, and grown in 96-well plates
(1 fish per well). 200 ll/embryo water per embryo with or with-
out 4PBA 0.05 mM or TUDCA 0.5 mM were added starting from
1 dpf to 11 dpf. Half of the volume was replaced with fresh
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solution every day. At 11 dpf fish were anesthetized with tri-
caine and lateral images were acquired using a Leica M165 FC
microscope connected to a Leica DFC425 C digital camera. The
caudal fin fold angle was evaluated, as described above, and
used for genotyping. The fish collection mode varied based on
the different experiments as detailed below.
For the long-term treatment, 4PBA was dissolved in water as
described above for embryo treatment, and then larvae were
transferred into tanks filled with 200 ml system water. Half of
the volume was replaced every day with fresh solution, and fish
were fed as described. The animals were sacrificed at
3.5 months. Digital images and X-ray were acquired. Then the
fish were fixed in 4% PFA w/v in PBS for alcian blue and alizarin
red staining. Morphometric analysis and mineralization level of
5th ceratobranchyal, cleithrum and notochord were performed
as described above.
Western blot
4PBA treated or untreated mutant and WT 11 dpf embryos (4 for
each genotype and treatment) were pooled and proteins were
extracted using 20 ml of RIPA buffer (Tris–HCl 10 mM, pH 7.6,
EDTA 5 mM, pH 8.0, NaCl 140 mM, NP40 0.5% v/v) added with
protease inhibitors (EDTA 1.52 mg/ml, benzamidine 1.57 mg/ml,
N-etilmaleimide 0.25 mg/ml, phenylmethylosulfonylfluoride
1 mM). 3.5 mpf WT and Chi/þ 4PBA treated and untreated fish
caudal tails were cut, lysed in 100 ml/tail RIPA buffer containing
protease inhibitor and sonicated 5 times for 10 s. Samples were
centrifuged at 17 000g for 30 min, at 4 C to remove cellular
debris.
Proteins from two embryos or one tail were dissolved in
Laemmli buffer with dithiothreitol 100 mM, denaturated for 10 min
at 90 C, separated in SDS-PAGE on a 15% polyacrylamide gel and
transferred to a PVDF (GE Healthcare) membrane. Membrane was
blocked with BSA 5% w/v in PBS with Tween-20 0.05% v/v (Sigma
Aldrich) (T-TBS) and incubated with primary polyclonal Acetyl-
Histone H3 (Lys9) antibody (Thermo scientific, J.942.2) diluted
1:1000 in BSA 5% w/v in T-TBS or with primary polyclonal actin an-
tibody (1–19) (Santa Cruz Biotechnology, sc-1616) diluted 1:1000 in
2% w/v BSA in TBS-T overnight at 4 C. Donkey anti-rabbit IgG-HRP
antibody (Santa Cruz Biotechnology, sc-2077) or donkey anti-goat
IgG-HRP antibody (Santa Cruz Biotechnology, sc-2020) were used
as secondary antibodies both diluted 1:10 000 in BSA 2% w/v in
TBS-T, 1 h at RT. ECL Prime Western Blotting Detection Reagent
(GE Healthcare) was used for signal detection, membranes were
acquired with Image Quant LAS4000 (GE Healthcare) and analysed
using Image Quant TL (GE Healthcare) software.
qPCR
4PBA treated or untreated mutant and WT 11 dpf embryos were
pooled (n¼ 20 for each group, 3 groups for each genotype and
treatment) and RNA was extracted with Qiazol (Qiagen) follow-
ing manufacturer’s instructions. RNA quantity was determined
with NanoDrop spectrophotometer and RNA quality by agarose
gel electrophoresis. cDNA was synthesized from 1 mg of RNA us-
ing the High Capacity cDNA Transcription kit (Applied
Biosystems) according to the manufacturer’s protocol in a final
volume of 20 mL.
qPCR was performed in 25 mL with SYBR Select Master Mix
(Applied Biosystems) using the Mx3000P thermocycler
(Stratagene) and the MxPro software (Stratagene). The following
primers were used: for col1a1a (NM_199214.1) 5’-GAGT
GATGGGTGCTATTGG-3’ (1748–1766) and 5’-GGAATCCTCTG
TCACCTCTA-3’ (1996–1977); for bglap (NM_001083857.3) 5’-TG
ACGTGGCCTCTATCATCA-3’ (163–182) and 5’-TTTATAGGCGG
CGATGATTC-3’ (316–297); for sp7 (NM_212863.2) 5’-GCTCCAA
TCTTCACAGCACA-3’ (944–963) and 5’-GCTGTGGACAGGTTTCTT
CC-3’ (1166–1147); for actb1 (NM_131031.1) 5’-GAAGGAGATCACC
TCTCTTGCTC-3’ (995–1017) and 5’-GTTCTGTTTAGAAGCACTTC
CTGTG-3’ (1188–1164). The annealing temperature was 58 C for
bglap and sp7 amplification and 60 C for col1a1a. DDCt method
was used to compare gene expression in the different samples.
Statistical analysis
All values are expressed as mean 6 standard deviation. The WT
and Chi/þ comparisons were performed applying unpaired
parametric or non-parametric t test. Mineralization was evalu-
ated by three independent blinded operators and defined in
specific classes (beginning/no mineralization, incomplete min-
eralization, complete mineralization). Categorical variables
were summarized by percentage. Differences in mineralization
between treatments and genotypes were evaluated with Chi-
squared test. For statistic significance, P value<0.05 was consid-
ered. All the analyses were performed using STATA 12VR .
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